Salomon A, et al. Influenza increases invasive meningococcal disease risk in temperate countries. Clin Microbiol Infect. 2020 Jan 11.
OBJECTIVES:
Invasive meningococcal disease (IMD) is a severe bacterial infection that displays wintertime seasonality in temperate countries. Mechanisms driving seasonality are poorly understood and may include environmental conditions and/or respiratory virus infections. We evaluated the contribution of influenza and environmental conditions to IMD risk, using standardized methodology, across multiple geographical regions.
METHODS:
We evaluated 3,276 IMD cases occurring between January 1999 and December 2011 in 11 jurisdictions in Australia, Canada, France and The United States. Effects of environmental exposures, and normalized weekly influenza activity, on IMD risk were evaluated using a case-crossover design. Meta-analytic methods were used to evaluate homogeneity of effects and to identify sources of between-region heterogeneity.
RESULTS:
After adjustment for environmental factors, elevated influenza activity at a two-week lag was associated with increased IMD risk (adjusted OR per standard deviation increase 1.29, 95% CI: 1.04-1.59). This increase was homogeneous across jurisdictions studied. By contrast, although associations between environmental exposures and IMD were identified in individual jurisdictions, none were generalizable.
CONCLUSIONS:
Using a self-matched design that adjusts for both co-seasonality and case characteristics, we find that surges in influenza activity result in an acute increase in population-level IMD risk. This effect is seen across diverse geographic regions in North America, France, and Australia. The impact of influenza infection on downstream meningococcal risk should be considered a potential benefit of influenza immunization programs.
Invasive meningococcal disease (IMD) is a severe bacterial infection that displays wintertime seasonality in temperate countries. Mechanisms driving seasonality are poorly understood and may include environmental conditions and/or respiratory virus infections. We evaluated the contribution of influenza and environmental conditions to IMD risk, using standardized methodology, across multiple geographical regions.
METHODS:
We evaluated 3,276 IMD cases occurring between January 1999 and December 2011 in 11 jurisdictions in Australia, Canada, France and The United States. Effects of environmental exposures, and normalized weekly influenza activity, on IMD risk were evaluated using a case-crossover design. Meta-analytic methods were used to evaluate homogeneity of effects and to identify sources of between-region heterogeneity.
RESULTS:
After adjustment for environmental factors, elevated influenza activity at a two-week lag was associated with increased IMD risk (adjusted OR per standard deviation increase 1.29, 95% CI: 1.04-1.59). This increase was homogeneous across jurisdictions studied. By contrast, although associations between environmental exposures and IMD were identified in individual jurisdictions, none were generalizable.
CONCLUSIONS:
Using a self-matched design that adjusts for both co-seasonality and case characteristics, we find that surges in influenza activity result in an acute increase in population-level IMD risk. This effect is seen across diverse geographic regions in North America, France, and Australia. The impact of influenza infection on downstream meningococcal risk should be considered a potential benefit of influenza immunization programs.
See Also:
Latest articles in those days:
- Intranasal influenza virus-vectored vaccine offers protection against clade 2.3.4.4b H5N1 infection in small animal models 2 hours ago
- Mapping of stakeholders in avian influenza surveillance in Canada 14 hours ago
- [preprint]Population Immunity to Hemagglutinin Head, Stalk and Neuraminidase of Highly Pathogenic Avian Influenza 2.3.4.4b A(H5N1) viruses in the United States and the Impact of Seasonal Influenza on 1 days ago
- Airborne Influenza Virus Surveillance Platform Using Paper-Based Immunosensors and a Growth-Based Virus Aerosol Concentrator 1 days ago
- [preprint]A Human H5N1 Influenza Virus Expressing Bioluminescence for Evaluating Viral Infection and Identifying Therapeutic Interventions 2 days ago
[Go Top] [Close Window]